Back to Results
First PageMeta Content
Medicine / Chemistry / Benzamides / Organofluorides / Pyridines / Roflumilast / Chronic obstructive pulmonary disease / Acute exacerbation of chronic obstructive pulmonary disease / Chronic bronchitis / Health / Chronic lower respiratory diseases / Smoking


FDA ERRATA (dated[removed]To FDA Advisory Committee Briefing Documents PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING April 7, 2010 NDA[removed]: Daxas (roflumilast 500 mcg tablets)
Add to Reading List

Open Document

File Size: 93,68 KB

Share Result on Facebook
UPDATE